CCT3-mediated Th2 deviation in tumor microenvironment may link to a worse outcome for LUAD, since Th2 cytokines IL-4 IL-5, IL-9 and IL-13 trigger the differentiation of tumor-associated M2 macrophages [40]. This evidence concerns the gene IL13 and neoplasm.